Cardinal Health (CAH)
(Delayed Data from NYSE)
$98.91 USD
-4.07 (-3.95%)
Updated May 3, 2024 04:00 PM ET
After-Market: $98.90 -0.01 (-0.01%) 7:58 PM ET
3-Hold of 5 3
A Value A Growth A Momentum A VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
CAH 98.91 -4.07(-3.95%)
Will CAH be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for CAH based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for CAH
Compared to Estimates, Cardinal (CAH) Q3 Earnings: A Look at Key Metrics
Cardinal Health (CAH) Beats on Q3 Earnings, Ups '24 EPS View
CAH: What are Zacks experts saying now?
Zacks Private Portfolio Services
What You Should Know About Block (SQ) Ahead of Q1 Earnings
What You Should Do With MercadoLibre (MELI) Ahead of Q1 Earnings
What's in Store for These 5 Medical Device Stocks in Q1 Earnings?
Other News for CAH
5 Expected Dividend Increases In May 2024
This Is What Whales Are Betting On Cardinal Health
Analysts Offer Insights on Healthcare Companies: Cardinal Health (CAH), Kura Oncology (KURA) and Amgen (AMGN)
Cardinal Health price target lowered by $6 at Baird, here's why
Cardinal Health Q3 Earnings: Undervalued On Strong Guidance